9 completed, 8 recruiting, 4 unknown, 3 withdrawn. 28 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 28 | Completed 9, Recruiting 8, Unknown 4, Withdrawn 3, Not yet recruiting 2, Active not recruiting 1, Terminated 1 |
Follow Tablets: new trials by email Literature Review of Tablets trials Research Report on Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial enteric-coated aspirin tablets (100 mg once daily, Bayer Healthcare, specification: 100 mg/tablet), a placebo with identical or similar appearance, taste, smell, and packaging to the aspirin tablets - Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm | Early Phase 1 | Not yet recruiting | The General Hospital of Western Theater Command | 224 | 2026-02-20 | 2026-02-12 |
| Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina Macitentan 10 mg tablet, once daily. - Non-Coronary Obstructive Angina | Early Phase 1 | Recruiting | China-Japan Friendship Hospital | 40 | 2025-09-01 | 2026-02-06 |
| Improving Sleep Quality After Total Joint Arthroplasty ( TJA) Melatonin 5 mg, Placebo Oral Tablet, Magnesium 500Mg Oral Tablet - Pain After TJA | Early Phase 1 | Withdrawn | Stanford University | 2025-06-01 | 2025-04-11 | |
| Lipid Mediators & Cancer: Montelukast, SPM, and Almonds No Interventions, Sports Pro Resolve 4 g, Double Wood SPM 4 g - Colorectal Cancer, Sarcoma | Early Phase 1 | Not yet recruiting | University of South Florida | 56 | 2025-03-01 | 2025-03-20 |
| A Pilot Study on Reverse Aging (The REVERSE Study) Rapamycin (Tablets), Prolon diet - Aging | Early Phase 1 | Active not recruiting | The Christ Hospital | 52 | 2025-02-15 | 2026-01-21 |
| Evaluation of the Efficacy of MACitentan in the Treatment of CoronaryMICrovascular Angina (MACMIC) Macitentan 10 mg tablet, once daily. - Coronary Microvascular Angina, Macitentan | Early Phase 1 | Recruiting | China-Japan Friendship Hospital | 30 | 2024-11-01 | 2025-02-06 |
| Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use Placebo, Salsalate 750 MG Oral Tablet [DISALCID] - Electronic Cigarette Use, Endothelial Dysfunction | Early Phase 1 | Recruiting | University of Iowa | 24 | 2024-08-15 | 2026-10-29 |
| Ketones, SGLT2, HFrEF Empagliflozin 25 MG Oral Tablet, Placebo, Acipimox 250 Mg Oral Capsule - Type2diabetes, Heart Failure With Reduced Ejection Fraction | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 71 | 2024-01-25 | 2026-02-05 |
| The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults OxyCODONE 5 mg Oral Tablet, OxyCODONE 2.5 mg Oral Tablet, Placebo oxyCODONE Oral Tablet - Pain | Early Phase 1 | Recruiting | University of Florida | 45 | 2023-09-12 | 2026-11-20 |
| Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers Apixaban 5 mg Oral Dissolving Film (TAH3311) and Tablet (Eliquis®) - Healthy Volunteers, Fasting | Early Phase 1 | Completed | TAHO Pharmaceuticals Ltd. | 12 | 2022-12-05 | 2023-08-18 |
| Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches Colchicine 0.5 MG Oral Tablet - ST-Elevation Myocardial Infarction | Early Phase 1 | Completed | University of Brawijaya | 63 | 2022-10-20 | 2024-05-24 |
| Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis Vitamin B3 100 MG Oral Tablet, vitamin B9, Placebo - Periodontitis Stage I, Periodontal Diseases | Early Phase 1 | Unknown | Cairo University | 30 | 2022-07-01 | 2022-06-28 |
| Metformin Treatment in Progressive Multiple Sclerosis Metformin 500 Mg Oral Tablet, up to 4 tablets a day, Placebo oral tablet identical to metformin, up to 4 tablets a day - Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Early Phase 1 | Completed | University of California, Los Angeles | 23 | 2022-04-26 | 2025-07-22 |
| Ivermectin Repurposed for the Treatment of PKDL Ivermectin 6 MG Oral Tablet (2 tablets) - Post Kala Azar Dermal Leishmaniasis | Early Phase 1 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 10 | 2022-03-02 | 2026-01-08 |
| Lorazepam Effects on Neuroimaging Measures Lorazepam 1Mg Tablet, Placebo - Lorazepam, Neuroimaging | Early Phase 1 | Withdrawn | Northwell Health | 2022-01-01 | 2022-05-27 | |
| Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination OxyCODONE 5 mg Oral Tablet, Oxytocin nasal spray, Placebo Oxycodone - Pain | Early Phase 1 | Recruiting | University of Florida | 45 | 2021-09-02 | 2026-11-20 |
| Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease Rivaroxaban 10 MG Oral Tablet [Xarelto] - Combined Anticoagulation and Antithrombotic Therapy, PAD - Peripheral Arterial Disease | Early Phase 1 | Unknown | Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi | 60 | 2021-07-02 | 2022-05-03 |
| Insulin Resistance Following ADT for Prostate CA Pioglitazone 30 Mg Oral Tablet, Pioglitazone placebo tablet - Insulin Resistance, Prostate Cancer | Early Phase 1 | Withdrawn | St. Louis University | 2020-12-02 | 2023-05-15 | |
| Pain Management Following Sinus Surgery Ibuprofen 600Mg Tablet, Standard Regimen | Tylenol - Nasal Sinus; Inflammation, Opioid Abuse | Early Phase 1 | Terminated | University of Nebraska | 10 | 2020-11-07 | 2023-09-06 |
| Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery Tranexamic Acid Injectable Product (1000 mg intravenous bolus), Vitamin C 250 MG Oral Tablet, Tranexamic Acid 650Mg Tablet - Open Posterior Thoracolumbar Spinal Fusion Procedure | Early Phase 1 | Recruiting | Rush University Medical Center | 604 | 2019-08-26 | 2026-01-08 |
Showing 20 of 28. Sign in to see all of them.
Inflammation (2) · Pain (2) · Brain Neoplasms (1) · Cardiovascular Diseases (1) · Colorectal Neoplasms (1) · Demyelinating Diseases (1) · Diabetes Mellitus (1) · Dyspepsia (1) · Endometrial Neoplasms (1) · Fasting (1) · Gout (1) · Hypertension (1) · Hyperuricemia (1) · Insulin Resistance (1) · Ketosis (1)
China-Japan Friendship Hospital (2) · University of Florida (2) · Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi (1) · Assiut University (1) · Cairo University (1) · Centro Neurológico de Pesquisa e Reabiitação, Brazil (1) · Hospital Civil de Guadalajara (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Mylan Pharmaceuticals Inc (1) · NewLink Genetics Corporation (1) · Northwell Health (1) · Rush University Medical Center (1) · St. Louis University (1) · Stanford University (1) · TAHO Pharmaceuticals Ltd. (1)
United States (17) · China (2) · Bangladesh (1) · Egypt (1) · Indonesia (1) · Mexico (1) · Pakistan (1) · United Kingdom (1)
Bruce T Czarnik, M.D. (1) · Bryce Basques, MD (1) · Cesar Minelli, MD, PhD (1) · Christie Barnes, MD (1) · Derek Amanatullah, M.D. PhD (1) · Enrique Cervantes-Perez, MD, MSc (1) · Eugene Kennedy, MD (1) · Gary Williamson, PhD (1) · Jorge Marcet (1) · Jose B Saenz, MD, PhD (1) · Juan A Gallego, MD (1) · Kevin R Patel, MD (1) · Meredith Berry, PhD (1) · Meredith S Berry, PhD (1)
PMID 10798549, PMID 11448564, PMID 12697586, PMID 14557966, PMID 17192170, PMID 19146007, PMID 21048170, PMID 21196541, PMID 21410904, PMID 21453653, PMID 21936146, PMID 22157565, PMID 2246576, PMID 24151279, PMID 25372846, PMID 25926990, PMID 26039598, PMID 26315980, PMID 26339415, PMID 26811272, PMID 27113948, PMID 27298661, PMID 27819381, PMID 27819386, PMID 36189306, PMID 36719647, PMID 37077913, PMID 3734600, PMID 38592213, PMID 40004876, PMID 40311885, PMID 40574863, PMID 40940923, PMID 41194247, PMID 41538301, PMID 41776652, PMID 42845554, PMID 8100894
K01DA052673 (1), R01CA277493 (1), R01DK107680 (1), R21DA056813 (1)